DSP and cardiomyopathy: Similarly, within the cohort of cardiomyopathy patients, the identification of arrhythmogenic variants within DSP, PKP2, and EMD (HGNC:3331, NM_000117.2) genes prompted discussions or further validated the decision regarding implantable cardioverter-defibrillator insertion for primary prevention of sudden cardiac death.